Skip to main content
. Author manuscript; available in PMC: 2019 Sep 4.
Published in final edited form as: ACS Pharmacol Transl Sci. 2019 Jul 17;2(4):247–263. doi: 10.1021/acsptsci.9b00020

Figure 6. Combination treatment displays synergistic mis-splicing rescue in HSALR DM1 mice.

Figure 6.

Splicing analysis of ES events determined via RNA-seq on HSALR mice treated with 600 mg kg−1 erythromycin (EM, green) or 10 mg kg−1 pafuramidine (PaF, blue) or a combination of both (EM+PaF, magenta) per oral administration daily for 14 days. (A) A scatter plot displaying the theoretical percent rescue based upon a purely additive effect by adding the percent rescues of erythromycin and pafuramidine alone (grey circles) and the actual percent rescue with the combination treatment (magenta squares) for the 142 ES events rescued by the combination treatment ordered by increasing theoretical percent rescue. Grey dotted lines mark 10 – 110 % rescue. The arrows denote the (B) Tnnt3 and (C) Tpd52l2 mis-splicing events which displayed synergistic rescue with combination treatment. Mean % rescue ± standard deviation values are displayed below each graph.